DOCSLIB.ORG

Stimulants in Belgium: Cocaine

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Stimulants in Belgium: Cocaine 17th International EWODOR Symposium “Pathways and challenges to addiction recovery: The role of treatment, self-help and other mechanisms of change” WELCOME SESSION On the need for recovery-oriented research, practices and policies Wouter Vanderplasschen, prof. dr. VAKGROEP ORTHOPEDAGOGIEK ONDERZOEKSGROEP HERSTEL EN VERSLAVING ON THE NEED FOR RECOVERY- ORIENTED RESEARCH, PRACTICES AND POLICIES Wouter Vanderplasschen, prof. dr. 1. WELCOME TO GHENT FOR THE XVIITH EWODOR SYMPOSIUM 5 ERIC BROEKAERT (1951-2016), EWODOR’S FOUNDER AND DRIVING FORCE EWODOR ̶ Founded in 1983 ̶ European Working Group on Drugs Oriented Research ̶ One of the oldest networks of drug researchers and practitioners in Europe ̶ Scientific branch of the EFTC ̶ Close collaboration between research and practice ̶ Treatment organisation supporting persons with drug problems and a university ̶ Vehicle to promote research-practice interactions and to exchange ideas regarding recovery-oriented practices in the field of substance abuse treatment 2. WHY RECOVERY? 8 BETTY FORD INSTITUTE CONSENSUS PANEL, 2007 “Recovery from substance dependence is a voluntarily maintained lifestyle, characterized by sobriety, personal health, and citizenship.” UK DRUG POLICY COMMISSION RECOVERY CONSENSUS GROUP, 2008 “The process of recovery from problematic substance use is characterised by voluntarily- sustained control over substance use, which maximises health and wellbeing and participation in the rights, roles and responsibilities of society.” MENTAL HEALTH RECOVERY Anthony (1993) defined recovery as "a deeply personal, unique process of changing one’s attitudes, values, feelings, goals, skills and/or roles. It is a way of living a satisfying, hopeful, and contributing life even with limitations caused by the illness. Recovery involves the development of new meaning and purpose in one’s life as one grows beyond the catastrophic effects of mental illness." AT LEAST TWO TYPES OF RECOVERY (SLADE ET AL., 2010) ̶ The first involves clinical recovery – when someone 'recovers' from the illness and no longer experiences its symptoms ̶ The second involves personal recovery – recovering a life worth living (without necessarily having a clinical recovery). It is about building a life that is satisfying, fulfilling and enjoyable. 3. WHY DO WE NEED A RECOVERY-ORIENTED APPROACHES? 13 ̶ Limitations of available substance use services: ̶ <3% of all persons entering MMT abstinent after 5 years (DORIS- study) ̶ High costs of (residential) treatment, poor and unsure outcomes ̶ Intergenerational dependence ̶ Often “treated as a junkie” ̶ Fragmented services + need for wrap-around support ̶ Involvement of service users + experts by experience generally limited ̶ Underutilisation of strengths and personal and social recovery capital ̶ Personal vs. societal treatment objectives (“parked on methadone”) ̶ Alternative to the chronic, relapsing brain disease model ̶ Support needed that is characterized by connectedness, hope, identity, meaning and empowerment (Leamy et al., 2012) 15 SOME RECENT DEVELOPMENTS TOWARDS RECOVERY-ORIENTED SUPPORT ̶ Emerging recovery movement in the US, Australia, Scotland, England, … ̶ Development of recovery-oriented drug and treatment policies in the UK, the Netherlands, Flanders, etc.. ̶ Renewed interest in AA, NA, and other types of self-help ̶ Private companies/ngo’s that focus on continuity of care rather tahn on primary treatment ̶ Recovery management check-ups ̶ Increased use of technology-based interventions ̶ Community-based support and activating the social network ̶ Growing research base on recovery ̶ Recovery-oriented systems of care RECOVERY PATHWAYS IN THE UK, THE NETHERLANDS AND BELGIUM WWW.REC-PATH.CO.UK FOCUS ON 5 POTENTIAL PATHWAYS TO RECOVERY 1. ‘natural recovery’ 2. 12-step self-help 3. Other self-supported recovery 4. Outpatient 5. Residential NEED FOR: ̶ Recovery-oriented policies ̶ Recovery-oriented practices ̶ Recovery-oriented research ̶ For supporting better, contributing lives and more inclusive societies, despite the limitations caused by addictions Prof. dr. Wouter Vanderplasschen Hoofddocent VAKGROEP ORTHOPEDAGOGIEK Ghent University @ugent E [email protected] Ghent University T +32 9 331 03 13 www.ugent.be Treatment and recovery and the reform of the mental health and addiction field in Belgium Dirk Vandevelde, Director of De Kiem (Belgium) No presentation available EWODOR: The oldest drug research Network in Europe Rowdy Yates, em. prof. EWODOR: The Oldest Drugs Research Network in Europe P. R. Yates, Honorary Senior Research Fellow, Scottish Addiction Studies, Faculty of Applied Social Science, University of Stirling, Scotland. President, European Federation of Therapeutic Communities Executive Director, European Working Group on Drugs Oriented Research e-mail: [email protected] url: https://eftc.ngo/ Founded in 1983, Rotterdam, The Netherlands Charles Kaplan, Eric Broekaert & Martien Kooyman saw a need to improve the scientific outputs from European therapeutic communities. Sustained & Developed for 35 years Eric Broekaert & Vera Segraeus extended the scope of EWODOR to encourage greater interest amongst academics and build bridges between the research and practitioner communities EWODOR - Early Symposia • 1983 – Erasmus UniversityRotterdam, The Netherlands • 1984 – Erasmus UniversityRotterdam, The Netherlands • 1985 – Erasmus UniversityRotterdam, The Netherlands • 1986 – Erasmus UniversityRotterdam, The Netherlands • 1988 – Erasmus UniversityRotterdam, The Netherlands • 1989 – Universiteit Gent, Belgium EWODOR Symposia in the 90s • 1990 – Universiteit Gent, Belgium • 1991 – La Sapienza Universita di Roma, Italy • 1993 – Universidad de Deusto (Bilbao), Spain • 1994 – Universidad de Deusto (Bilbao), Spain • 1996 – University of Stirling, Scotland • 1998 – Universidade do Porto, Portugal • 1999 – Universiteit Gent, Belgium EWODOR Symposia in the 00s • 2000 – Universiteit Gent, Belgium • 2001 – Universiteit Gent, Belgium • 2002 – CeIS Modena, Italy • 2003 – University of Stirling/Phoenix Futures, Scotland • 2004 – Aarhus Universitet, Denmark • 2005 – Universteit Gent (Blankenberge), Belgium • 2006 – STAKES (Helsinki), Finland • 2007 – Institutt fur Klinisk Medisin (Oslo), Norway • 2008 – Linnaeus University (Vaxjo), Sweden • 2009 – University of Stirling/Phoenix Futures, Scotland EWODOR Symposia in the 10s • 2011 – Universidad de Barcelona/Proyecto Hombre, Spain (Catalonia) • 2012 – Aristotle University/KETHEA(Thessaloniki) Greece • 2014 – Trinity College Dublin/Coolmine TC, Ireland • 2016 – Lumsa Universita/Dianova (Rome) Italy • 2018 – Universiteit Gent/ De Kiem TC, Belgium EWODOR Symposia: Changes and Trends • A total of 28 symposia/meetings (not 17!!!!) • An increasing emphasis on co-organising with TCs • An increasing emphasis on publishing proceedings in peer-reviewed journals • Proceedings published in various monographs and in International Journal of Social Welfare, European Addiction Research, International Journal of Therapeutic Communities, Journal of Substance Abuse, (+ edited book published by Universidad de Barcelona Medical School). EWODOR: Milestones • IPTRP – 1994. A major international comparative study of parallel disorders amongst TC residents • Involved academics from 9 European universities and utilised 28 separate field sites • 1996 – EWODOR establishes an online discussion forum for addiction researchers • 2003 – EWODOR pilots a multinational online course using lecturers from 5 European universities • Original Goals – improve scientific understanding amongst TC staff; encourage addiction interest amongst academics; and create a bridge between the research and practitioner communities EWODOR 2018 Eric Broekaert 1951–2016: The Lord of the Dance Drug treatment demand and drug- related problems in Belgium Lies Gremeaux, dr. Drug Treatment demand and drug-related problems in Belgium 17th International EWODOR Symposium - 2018 dr Lies Gremeaux Belgian Reitox national focal point Epidemiology and public health SCIENSANO Mission of EMCDDA & the Reitox Network National Focal Points in 28 Member States (+ Norway and Turkey) Collect objective and reliable information on the drug situation Support an evidence-based drug policy Information system for national and international policy makers & professionals The drug problem in Belgium at a glance Overview: 1. Treatment entries in Belgium: Key data and trends 2. Current situation and developments for the main substances of (ab)use 3. Conclusions TREATMENT OF SUBSTANCE USE IN BELGIUM: WHAT WE KNOW (AND WHAT WE DON’T KNOW) Drug treatment in Belgium: setting and number treated A. Treatment demand indicator (TDI) register • Key Indicator EMCDDA • New entries for problematic use of alcohol or illicit substances = incidence! • Registration since 2011 • Use of the national identification number Drug treatment in Belgium: setting and number treated (2017) A. Treatment demands (Outpatient & Inpatient) : 12,037 Illicit Substances Drug treatment in Belgium: setting and number treated (2017) A. Treatment demands (Outpatient & Inpatient) : 12,037 B. Opioid Substitution Treatment (OST) : 16,453 4% 15% Methadon Buprenorphine both 81% Source: OST register, Sciensano Drug treatment in Belgium: setting and number treated (2017) A. Treatment demands (Outpatient & Inpatient) : 12,037 B. Opioid Substitution Treatment (OST) : 16,453 C. Census Prison OST : 706 TOTAL 2017 ~29,289 D. Alcohol (TDI) ~9,200 – 12,000 Treatment demands by substance type 2017 50% ! Source: TDI register, Sciensano
Load more

Recommended publications
  • Drug Law Reform: Moving Beyond Strict Criminal Penalties for Drugs
    Drug law reform: Moving beyond strict criminal penalties for drugs Professor Simon Lenton Deputy Director, NDRI Introduction The term ‘decriminalisation’ can confuse the discussion about drug policy reform as it means so many different things to different people. Indeed many confuse ‘decriminalisation’ with ‘legalisation’, that is, making some aspect of the drug possession/use no longer an offence. More correctly, the term is used to refer to refer to what is termed prohibition with civil penalties, that is, much like speeding in a motor vehicle – illegal, not condoned, but only attracting civil penalties like a fine, with no further criminal actions taken if the fine is paid by the due date. It is likely that others use it as a generic term meaning reducing penalties in comparison to total prohibition with strict criminal penalties. The confusion about what decriminalisation means is problematic for a number of reasons. Firstly, sensible discussion of drug policy options is impossible when the meanings of terms aren’t shared. Secondly, we tend to be scared of what we don’t understand. Consequently, it is unsurprising that the latest Nielsen poll has found that public support for ‘decriminalisation’ is low, at only 27% (1). Previously it has been found that when the term was explained, support for applying prohibition with civil penalties to cannabis use increased from 64% to 72% (2). According to the National Drug Strategy Survey Australian public support for criminal penalties for possession of cannabis has remained low, ranging from 34% to 39%, in the four surveys conducted between 2001 and 2010. Interestingly, support for legalisation of cannabis use has been even lower declining from 31% in 2001 to 25% in 2010.
    [Show full text]
  • Drugs, Crime and Statistics a Hangover for Life Prison Needle Exchange Controversy Quit Or Die, You Have Another Choice Contents
    Drugs, crime and statistics A hangover for life Prison needle exchange controversy Quit or die, you have another choice Contents matters of substance November 2007 Features Vol 17 No 4 ISSN 1177-200X 02 Cover Story Is alcohol-related brain Mike Webb of the matters of substance is published by the Let’s talk about pot impairment a silent New Zealand Police writes NZ Drug Foundation. All rights reserved. but growing epidemic about a major review of Neither this publication nor any part amongst heavy drinking the Police Act, which is of it may be reproduced without prior permission of the NZ Drug Foundation. New Zealanders? New currently underway, and the research suggests our opportunities this might bring matters of substance invites feedback culture of drunkenness about for harm minimisation and contributions. If you’re interested in may be putting our brains at the frontline of policing. contributing a guest editorial or article, at risk, and most won’t please first contact us: know until it’s too late. [email protected] Marijuana. It’s the most 29 Mythbusters p +64 4 801 6303 widely used and least talked Hard time and about (illicit) recreational Regulars hard numbers Brand development/graphic design drug in New Zealand. In this Origin Design +64 4 801 6644 [email protected] special edition of Matters of 01 The Director’s Cut Substance, we’ve asked Drug Foundation Director interested and interesting NZ Drug Foundation Ross Bell writes about 3rd Floor, 111 Dixon Street people from across the current drug law review in PO Box 3082, Wellington, New Zealand cannabis spectrum to share New Zealand.
    [Show full text]
  • “BELGIUM” New Development, Trends and In-Depth Information on Selected Issues
    BELGIAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION Scientific Institute of Public Health OD Public health and Surveillance 2012 NATIONAL REPORT (2011 DATA ) TO THE EMCDDA BY THE REITOX NATIONAL FOCAL POINT “BELGIUM” New Development, Trends and in-depth information on selected issues REITOX Belgian national report on drugs 2012 OD Public Health and Surveillance, Scientific Institute of Public Health, October 2011, Brussels, Belgium WIV-ISP/EPI REPORTS Belgian national report on drugs 2012 Els Plettinckx Jerome Antoine Kaatje Bollaerts Peter Blanckaert Johan C.H. van Bussel EMCDDA Management Board Mr. Claude GILLARD , Legal adviser, Head of the Department of criminal law, Direction Générale de la législation du Service Public Fédéral Justice Dr. Philippe DEMOULIN , Deputy Director General f.f., Administration de la Communauté française de Belgique EMCDDA Scientific Committee Prof. Dr. Brice DE RUYVER , Full Professor, Institute for International Research on Criminal Policy (IRCP), University of Ghent Ministers involved in the global and integrated drug policy in Belgium 2012 For the Federal State: Mr. Elio DI RUPO , Prime Minister. Mrs. Laurette ONKELINX , Vice Prime Minister and Minister of Public Health and Social Affairs, in charge of Beleris and the Federal Cultural Institutions. Mme. Joelle MILQUET, Vice-Prime Minister and Minister of the interior and Equal Opportunities. Mr. Didier REYNDERS, Vice-Prime Minister and Minister of Foreign Affairs, International Trade and European Affairs. Mr. Steven VANACKERE , Vice-Prime Minister, and Minister of Finance and sustainable development, in charge of official affairs. Mr. Vincent VAN QUICKENBORNE , Vice-Prime Minister and Minister of Pensions. Mr. Johan VANDE LANOTTE , Vice-Prime Minister and Minister of Economy, Consumers and North Sea.
    [Show full text]
  • DE REGULERING VAN CANNABIS. LESSEN UIT HET VERLEDEN EN DENKSPOREN VOOR DE TOEKOMST Thorbeckecolleges
    DE REGULERING VAN CANNABIS. LESSEN UIT HET VERLEDEN EN DENKSPOREN VOOR DE TOEKOMST Thorbeckecolleges Voordrachten gehouden in het kader van de uitwisseling tussen de juridische faculteiten te Gent en te Leiden Thorbeckecollege 37 De regulering van cannabis. Lessen uit het verleden en denksporen voor de toekomst Voordracht gehouden aan de Universiteit te Leiden Faculteit Rechtsgeleerdheid op 14 maart 2013 door Tom Decorte Hoogleraar criminologie aan de Universiteit Gent ISBN 978 90 4656 864 4 D 2014 2664 531 BP/GANDTOR-BI14001 Verantwoordelijke uitgever: Hans Suijkerbuijk Ragheno Business Park Motstraat 30 B-2800 Mechelen Tel.: 0800-14500 (gratis nummer) www.kluwer.be # 2014, Wolters Kluwer Belgium NV Behoudens de uitdrukkelijk bij Wet bepaalde uitzonderingen mag niets uit deze uitgave worden verveelvoudigd, opgeslagen in een geautomatiseerd gegevensbestand, of openbaar gemaakt, op welke wijze dan ook, zonder de uitdrukkelijke voorafgaande en schriftelijke toestemming van de uitgever. Inhoudstafel 1. Inleiding 1 2. De uitgangspunten van het Belgische drugsbeleid 4 3. Het Belgische cannabisbeleid faalt 7 3.1. Cannabisgebruik onder de algemene bevolking 8 3.2. Cannabisgebruik onder scholieren 9 3.3. Hulpvragen in verband met cannabis 9 4. De paradox van de repressieve aanpak 12 4.1. Push-factor voor professionele criminelen 13 4.2. Ballon- of waterbedeffecten 14 4.3. Selectieve en disproportionele aanpak 16 4.4. Interne inconsistentie 17 5. Criminogene effecten 18 4.6. Geen kwaliteitscontrole: nefast voor de volksgezondheid 20 4.7. Slachtoffers van het beleid 21 4.8. Niet kosteneffectief en niet ‘evidence-based’ 25 5. Regulering: een waaier aan opties 29 5.1. Regulering van de productie 29 5.2.
    [Show full text]
  • Global Atlas of AIS-Based Fishing Activity Challenges and Opportunities
    Global Atlas of AIS-based fishing activity Challenges and opportunities 1 Global Atlas of AIS-based fishing activity Challenges and opportunities M. Taconet, D. Kroodsma and J. A. Fernandes FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS Rome, 2019 Required citation: Taconet, M., Kroodsma, D., & Fernandes, J.A. 2019. Global Atlas of AIS-based fishing activity - Challenges and opportunities. Rome, FAO. (also available at www.fao.org/3/ca7012en/ca7012en.pdf). The designations employed and the presentation of material in this information product do not imply the expression of any opinion whatsoever on the part of the Food and Agriculture Organization of the United Nations (FAO) concerning the legal or development status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. The mention of specific companies or products of manufacturers, whether or not these have been patented, does not imply that these have been endorsed or recommended by FAO in preference to others of a similar nature that are not mentioned. Dashed lines on maps represent approximate border lines for which there may not yet be full agreement. All maps conform to United Nations World map, February 2019. https://www.un.org/Depts/Cartographic/english/htmain.htm The views expressed in this information product are those of the author(s) and do not necessarily reflect the views or policies of AO.F ISBN 978-92-5-131964-2 © FAO, 2019 Some rights reserved. This work is made available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo/legalcode/legalcode).
    [Show full text]
  • Cannabis Social Clubs in Belgium: Recent Developments
    Cannabis Social Clubs in Belgium: recent developments Author and affiliation: Tom Decorte Professor of Criminology Institute for Social Drug research (ISD) Ghent University Correspondence: Prof. Dr. Tom Decorte Institute for Social Drug research (ISD) Ghent University Universiteitsstraat 4, B-9000 Ghent, BELGIUM Tel.: 00 32 (0) 9 264 69 62 E-mail: [email protected] 1 1. Introduction Cannabis Social Clubs (CSCs) are a proposal of self-production and self-distribution of cannabis for the personal use of adults, which are organized in non-profit systems of shared responsibility with the goal of reducing the risks and harms associated with cannabis bought on the black market (Room et al., 2010; Barriuso, 2005; 2011). CSCs are legal non-profit associations whose members are adult cannabis users, most of whom use it recreationally, although others use cannabis medicinally. The CSCs organize a professional, collective cultivation of limited quantities of cannabis to cover the personal needs of their members and the system is regulated by security and quality checks. ‘Cannabis social clubs’ can be found in many countries, but the label often covers very different empirical realities. Uruguay, the first country in the world that has recently legalized cannabis, allows - next to regulated production and sale of cannabis in pharmacies and home production (up to six plants for personal use) - cannabis production by collectives (Bewley-Taylor, Blickman & Jelsma, 2014). These ‘clubs’ may have 15 to 45 members and are allowed to cultivate up to 99 plants (proportionally to the number of members). On the other hand, studies on domestic cannabis cultivation have shown repeatedly that even in an illegal context, users and growers can be part of informal networks or co-operatives of cannabis producers (Potter, 2010; Decorte, 2010a).
    [Show full text]
  • A STUDY of CANNABIS SOCIAL CLUBS in BELGIUM Insights Into the Supply Model, the Movement, and Its Key Actors
    A STUDY OF CANNABIS SOCIAL CLUBS IN BELGIUM Insights into the supply model, the movement, and its key actors Mafalda Pardal Supervisors: Prof. Dr. Tom Decorte, Prof. Dr. Letizia Paoli (KU Leuven) Dissertation submitted to obtain the academic degree Doctor (Ph.D.) in Criminology Academic year: 2017 - 2018 A STUDY OF CANNABIS SOCIAL CLUBS IN BELGIUM Insights into the supply model, the movement, and its key actors Mafalda Pardal Dissertation submitted to obtain the academic degree Doctor (Ph.D.) in Criminology Supervisors: Prof. dr. Tom Decorte Prof. dr. Letizia Paoli Doctoral Guidance Committee: Prof. dr. Freya Vander Laenen Prof. dr. Beau Kilmer Department of Criminology, Criminal Law and Social Law Ghent University, Belgium Academic year 2017-2018 Acknowledgments Acknowledgments I first learned about Cannabis Social Clubs (CSCs) in 2013 while conducting research at RAND Europe. I was intrigued by both the idea of this cooperative-like, grassroots model of supply for cannabis and by the lack of visibility of the model in the scholarly and policy debates about potential scenarios for cannabis legalization. Five years on, I am very grateful to have had the opportunity to deepen my understanding of the model, and I am deeply indebted to all the Belgian Cannabis Social Club representatives, cannabis growers, members, and all other individuals who have allowed me to enter the Belgian CSC field and tolerated my many questions during the past three years, often in very trying circumstances. Thank you for your trust. It has been a privilege to work under the supervision of Prof. Dr. Tom Decorte and Prof. Dr.
    [Show full text]
  • Decorte, T. (2010). Small Scale Domestic Cannabis Cultivation: an Anonymous Web Survey Among 659 Cannabis Cultivators in Belgium
    This is the peer reviewed version of the following article: Decorte, T. (2010). Small scale domestic cannabis cultivation: An anonymous Web survey among 659 cannabis cultivators in Belgium. Contemporary Drug Problems, 37, 341-370. which has been published in final form at https://doi.org/10.1177/009145091003700208 This article may be used for non-commercial purposes in accordance with SAGE’s Archiving and Sharing Policy © 2010. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/ Small scale domestic cannabis cultivation: an anonymous web survey among 659 cannabis cultivators in Belgium (Revised version – 15 September 2009) Prof. Dr. Tom Decorte Correspondence: Prof. Dr. Tom Decorte Institute for Social Drug Research Ghent University Universiteitstraat 4 B-9000 Gent BELGIUM Tel: + 32 (0)9 264.69.62 E-mail: [email protected] [1] Small scale domestic cannabis cultivation in Belgium: findings from an anonymous web survey Abstract The shift to (inter)regional production, trade and domestic cultivation has become an irreversible international trend. Until now, the focus of most empirical work has been on large-scale, commercially oriented and professionally organized segments of the cannabis industry, often based on police data and on the perspective of law enforcement agencies. This paper presents some significant findings from a large-scale study on a less visible and less studied segment of the market, i.e. small-scale cultivators, based on an anonymous web survey among 659 cannabis cultivators. The paper discusses the patterns of cultivation, some technical aspects of growing operations, (dis)advantages of cannabis cultivation, and perceived quality and strength of home-grown cannabis.
    [Show full text]
  • View Attachment 7096937-All-About
    All about Hemp 1.1 ~ Introduction The fiber of Cannabis, the "True Hemp", is tightly woven into the tapestry of human life. Since earliest times, this great plant ally has provided people with cordage, cloth, paper, medicine, and inspiration. For all the many benefits it bestows, Cannabis hemp is a friendship well worth cultivating. Hemp is many things to many people, and it is known by hundreds of names. Poets sing its praises, and preachers damn it. Executioners hang condemned men with hemp rope, but sailors and mountaineers hang onto it for dear life. Doctors prescribe it as a medicine, yet prohibitionists proscribe it as a poison. Armies and navies make war with hemp, while lovers use it as an aphrodisiac. The resinous virtue generates real happiness, enlightenment and entertainment, equal in quality and worth to the similar joys of love, freedom, and good health --- and it complements them all, and it comforts those poor souls who are without such blessings. Hemp is a most interesting and paradoxical plant, one that defies control and begs understanding. Hemp is one of mankind's best (and few) friends on Earth, yet it is a prisoner within its own cells, bound in a Gordian Knot of laws. Yet again, hemp is Ariadne's Thread, a guideline out of the labyrinth of bureaucratic tyranny and into a new state of liberty and grace. James Allen expressed the sentiment most passionately in the closing words of The Reign ofLaw (1900): "O Mystery immortal! which is in the hemp and in our souls, in its bloom and in our passions, by which our poor brief lives are led upward out of the earth for a season, then cut down, rotted, and broken --- for Thy long service!" (1) 1.2 ~ Hemp & Health Cannabis has been used in medicine since about 2300 B.C., when the legendary Chinese Emperor Shen-Nung prescribed chu-ma (female hemp) for the treatment of constipation, gout, beri-beri, malaria, rheumatism, and menstrual problems.
    [Show full text]
  • A Way out of the Deadlock
    chapter 1 General Introduction: A Way Out of the Deadlock 1.1 The Subject of this Discourse As already indicated in the preface, the discussion concerning the legalization of cannabis is not only taking place in Belgium and the Netherlands, but also in North and South America. However, a lot more can be told about it. The same discussion is also going on in a number of other member states of the European Union and within the United Nations. So we may state that we are dealing with a glocal discussion. In other words, a discussion which takes place both globally and locally, and at all the intermediate (sub)continental levels. It could hardly be otherwise. Within the framework of the United Nations coun- tries have engaged themselves – by way of treaties – to a certain worldwide drug policy, which also affects their cannabis policy. Because of the nowadays available, enormous and worldwide transportation, communication and pay- ment possibilities, it should not be neglected that also the drug trade is operat- ing on a global scale. Thus, to ensure a balanced local or national discussion about the drug pol- icy, the participants to that discussion have to pay attention not only to the local situation, but also to the worldwide context. But in the heat of the debate this is easily forgotten and the international context is not, or not always suffi- ciently, taken into account. The pamphlets that some time ago stirred the con- stantly simmering discussion about the legalization of cannabis in Belgium and the Netherlands have conclusively demonstrated this.
    [Show full text]
  • Cannabis Legal Regulatory Update April
    Allen & Overy | Cannabis Legal & Regulatory Update View this email in your browser Cannabis Legal & Regulatory Update April ­ June 2019 PDF version The A&O view It’s been another busy couple of months for the cannabis industry. Following the European Parliament’s resolution earlier this year, a surge in medical cannabis pilot programmes and burgeoning legalisation trend can be observed in European countries (France, Ireland, Romania, Belgium, Switzerland…). Countries that already allowed the therapeutic use of cannabis are seeking to expand access to patients by increasing supply, either through local cultivation (Germany) or increased imports (Italy), while others are called upon to further fine­ tune their recent regulations (UK). Less progress has been made in the CBD well­being market, where authorities seem hesitant to issue – much needed – official guidance that is tailored to different product types, exposing the industry to even more legal uncertainty by randomly issuing what often seem to be capricious (and mostly non­binding) statements. National courts (in France, Italy, Czech Republic…) are beginning to pick sides in this complex matter, but it seems that, ultimately, the European Court of Justice (in the pending referral C­ 663/18) may have to take a clear stance on member states’ margin of manoeuvre in light of the EU’s fundamental free movement of goods. Meanwhile, interest in the European market is on the rise, and in addition to cannabis­oriented growth companies and funds, multinational corporations, investment banks and major financial institutions across a broad variety of industries are beginning to – carefully – explore this booming sector. As the legal cannabis market is set to be worth billions in the near future, it is hardly surprising that everyone wants a piece of the pie.
    [Show full text]
  • Sources of Value in the Cannabis Industry: the Case of Canadian Public Companies
    UNIVERSITY OF LJUBLJANA SCHOOL OF ECONOMICS AND BUSINESS MASTER’S THESIS SOURCES OF VALUE IN THE CANNABIS INDUSTRY: THE CASE OF CANADIAN PUBLIC COMPANIES Ljubljana, December 2019 MARK MALIS AUTHORSHIP STATEMENT The undersigned Mark Malis, a student at the University of Ljubljana, School of Economics and Business, (hereafter: SEB LU), author of this master’s thesis with the title THE SOURCES OF VALUE IN THE CANNABIS INDUSTRY: THE CASE OF CANADIAN PUBLIC COMPANIES, prepared under supervision of Professor Aljoša Valentinčič, PhD, DECLARE 1. this master’s thesis to be based on the results of my own research; 2. the printed form of this master’s thesis to be identical to its electronic form; 3. the text of this master’s thesis to be language-edited and technically in adherence with the SEB LU’s Technical Guidelines for Written Works, which means that I cited and / or quoted works and opinions of other authors in this master’s thesis in accordance with the SEB LU’s Technical Guidelines for Written Works; 4. to be aware of the fact that plagiarism (in written or graphical form) is a criminal offence and can be prosecuted in accordance with the Criminal Code of the Republic of Slovenia; 5. to be aware of the consequences a proven plagiarism charge based on the this written final work could have for my status at the SEB LU in accordance with the relevant SEB LU Rules; 6. to have obtained all the necessary permits to use the data and works of other authors which are (in written or graphical form) referred to in this master’s thesis and to have clearly marked them; 7.
    [Show full text]